title: [Impact of VEGF-A in exhaustion of intratumoral T cells].
authors.affiliation: Inserm U970, PARCC (Paris cardiovascular research center), Université Paris-Descartes, Sorbonne Paris Cité, 56, rue Leblanc, 75015 Paris, France.
authors.forename: Thibault
authors.initials: T
authors.lastname: Voron
authors.affiliation: Inserm U970, PARCC (Paris cardiovascular research center), Université Paris-Descartes, Sorbonne Paris Cité, 56, rue Leblanc, 75015 Paris, France - Service d'immunologie biologique, hôpital européen Georges Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France.
authors.forename: Éric
authors.initials: É
authors.lastname: Tartour
authors.affiliation: Inserm U970, PARCC (Paris cardiovascular research center), Université Paris-Descartes, Sorbonne Paris Cité, 56, rue Leblanc, 75015 Paris, France - Service d'hépatogastroentérologie et d'oncologie digestive, hôpital européen Georges Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Taieb
authors.affiliation: Inserm U970, PARCC (Paris cardiovascular research center), Université Paris-Descartes, Sorbonne Paris Cité, 56, rue Leblanc, 75015 Paris, France.
authors.forename: Magali
authors.initials: M
authors.lastname: Terme
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D000077210:Sunitinib; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D009363:Neoplasm Proteins; C105992:PDCD1 protein, human; C491383:Pdcd1 protein, mouse; D061026:Programmed Cell Death 1 Receptor; D011758:Pyrroles; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse; D040262:Receptors, Vascular Endothelial Growth Factor; D000077210:Sunitinib